3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid
C21H22N4O2 — CID 147508081
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid
3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid (PubChem CID 147508081) has the molecular formula C21H22N4O2 and a molecular weight of 362.43 g/mol. Its IUPAC name is 3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid.
Molecular Properties
| Compound Name | 3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid |
|---|---|
| PubChem CID | 147508081 |
| Molecular Formula | C21H22N4O2 |
| Molecular Weight | 362.43 g/mol |
| Exact Mass | 362.17 |
| IUPAC Name | 3-[(4-phenyl-1-piperidin-3-ylpyrazol-3-yl)methyl]pyridine-4-carboxylic acid |
| SMILES | O=C(O)c1ccncc1Cc1nn(C2CCCNC2)cc1-c1ccccc1 |
| InChI | InChI=1S/C21H22N4O2/c26-21(27)18-8-10-23-12-16(18)11-20-19(15-5-2-1-3-6-15)14-25(24-20)17-7-4-9-22-13-17/h1-3,5-6,8,10,12,14,17,22H,4,7,9,11,13H2,(H,26,27) |
| InChIKey | FISSYKWXTDGWQN-UHFFFAOYSA-N |
| XLogP | 3.16 |
| TPSA | 80.04 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.43 |
| LogP ≤ 5 | 3.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147508081 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.